好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2020 Annual Meeting | C156 - Pediatric Neuro-oncology Update: Advances in Cures and Long-term Survivorship

Tuesday 04/28/20
03:30 PM - 05:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Sonia Partap, MD, FAAN
Child Neurology and Developmental Neurology, Neuro-oncology
Participants should be able to understand the current treatment strategies of pediatric CNS tumors, become familiar with the acute neurologic sequelae related to tumor and or therapies, and anticipate late neurologic effects in survivors of these cancers.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Audience Participation
Event Timeline
03:30 PM - 04:00 PM Speaker Epidemiology and Review of Current Pediatric CNS Treatments
Sonia Partap, MD, FAAN
04:00 PM - 04:45 PM Speaker CAR-T Toxicities in Pediatric Cancer Patients
Juliane Gust, MD, PhD
04:45 PM - 05:30 PM Speaker Neurologic Sequelae in Adult Survivors of Pediatric CNS Tumors
Nicole Ullrich, MD, PhD, MMSci, FAAN
Faculty Disclosures
Sonia Partap, MD, FAAN The institution of Dr. Partap has received research support from NIH.
Nicole Ullrich, MD, PhD, MMSci, FAAN Dr. Ullrich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. The institution of Dr. Ullrich has received research support from Children's Tumor Foundation. Dr. Ullrich has received intellectual property interests from a discovery or technology relating to health care. Dr. Ullrich has received publishing royalties from a publication relating to health care.
Juliane Gust, MD, PhD The institution of Dr. Gust has received research support from NINDS.